Market Closed

TLSI
TriSalus Life Sciences
$ 2.43
-3.57%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

TriSalus Life Sciences News

Latest TriSalus Life Sciences Stock News & TLSI Headlines

TriSalus Life Sciences Q3 Earnings Call Highlights
5 days ago | marketbeat.com
TriSalus Life Sciences, Inc. (TLSI) Q3 2026 Earnings Call Transcript
5 days ago | seekingalpha.com
TriSalus Life Sciences Reports Third Quarter 2026 Results
5 days ago | businesswire.com
TriSalus Life Sciences to Host Third Quarter 2026 Financial Results Conference Call
25 days ago | businesswire.com
TriSalus Secures FDA Clearance For TriNav Advance as Stock Tests Key Support
2 months ago | benzinga.com
TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday
2 months ago | benzinga.com
TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug Delivery™ (PEDD™) Portfolio for Liver Embolization
2 months ago | businesswire.com
TriSalus Highlights Tumor-Treatment Expansion, FDA Catalyst at Growth Conference
3 months ago | marketbeat.com
TriSalus Life Sciences Q2 Earnings Call Highlights
3 months ago | marketbeat.com
TriSalus Life Sciences, Inc. (TLSI) Q2 2026 Earnings Call Transcript
3 months ago | seekingalpha.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

TLSI
TriSalus Life Sciences
$ 2.43
-3.57%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago